References
Raison CL et al. Am J Psychiatry 2003; 160: 1554–1565.
Licinio J et al. Mol Psychiatry 1999; 4: 317–327.
Pariante CM et al. Biol Psychiatry 2001; 49: 391–404.
Wang X et al. Mol Psychiatry 2004; 9: 65–75.
Rogatsky I et al. Proc Natl Acad Sci USA 1998; 95: 2050–2055.
McKay LI et al. Mol Endocrinol 1998; 12: 45–56.
Pariante CM et al. J Endocrinol 2001; 169: 309–320.
Paccani SR et al. J Biol Chem 2002; 277: 1509–1513.
Pariante CM et al. Mol Pharmacol 1997; 52: 571–581.
Murray HJ et al. Neuropharmacology 2003; 44: 374–380.
Monje ML et al. Science 2003; 302: 1760–1765.
Acknowledgements
This work was supported in part by grants from the National Institute of Mental Health (MH-067041) and the Emory University Research Committee Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, F., Wang, X., Pace, T. et al. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 10, 426–428 (2005). https://doi.org/10.1038/sj.mp.4001644
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001644
- Springer Nature Limited
This article is cited by
-
Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities
Neurochemical Research (2021)
-
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
Molecular Psychiatry (2018)
-
Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress
Molecular and Cellular Biochemistry (2014)
-
Inflammatory Biomarkers and Depression
Neurotoxicity Research (2011)
-
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy
European Archives of Psychiatry and Clinical Neuroscience (2008)